Conclusion:
Only 62% of COVID-19 patients with self-reported olfactory dysfunction have anosmia or hyposmia on objective psychophysical olfactory evaluation. Interestingly, the majority of those with confirmed objective olfactory dysfunction did not have nasal inflammatory symptoms, supporting the need of future clinical and experimental studies to clarify the pathophysiological mechanisms underlying the development of anosmia in COVID-19.
Funding : FRMH Funding.
Conflict of interest statement : The authors have no conflicts of interest
Acknowledgments: -.